Skip to content

The Archives of Pharmacy and Pharmaceutical Sciences (APPS) is a peer-reviewed, open-access journal serving the global pharmacy and pharmaceutical science community. APPS publishes research spanning discovery, development, manufacturing, and practice to help “redefine how drugs will be developed, evaluated and manufactured,” as articulated on the journal’s site. Source: APPS Homepage

Journal at a Glance

2639-992X

Shown on the journal’s Article Processing Charges page alongside the APC table. Source

Double-blind

Declared in the Peer Review Policy. Source

CC BY 4.0

Stated on the Licensing Policy page. Source

Index Copernicus (ICV 88.77)

Displayed on the site header area. Source

Scope in brief: The “About” and “Aims and Scope” materials emphasize comprehensive coverage across medicinal/pharmaceutical chemistry, pharmaceutics and delivery, biopharmaceutics, pharmacology/therapeutics, analysis & quality, regulatory science, pharmacovigilance, and pharmacy practice. Sources: About, Aims & Scope

Mission & Publishing Model

The About page introduces APPS as a venue for “judiciously peer-reviewed manuscripts” that enhance knowledge in pharmaceutical sciences and address sector challenges such as R&D productivity, generic competition, and patent expirations. The journal positions itself to publish work that boosts competitiveness and creativity in the pharmaceutical sciences.

APPS operates as an open-access journal. The Open Access Policy page notes that all manuscripts are published under open-access terms and references the BBB (Budapest, Bethesda, Berlin) framing of open access, while the Licensing Policy confirms use of the Creative Commons Attribution 4.0 International (CC BY 4.0) license.

To sustain open access, APPS charges an APC after acceptance; the APC and waiver approach are described on the Article Processing Charges and Waiver Policy pages.

What APPS Publishes

Research Articles

Full reports featuring robust methodology across discovery, formulation, delivery, pharmacology, and practice.

Short Communications

Concise advances and timely notes that merit rapid dissemination.

Reviews / Mini-reviews

Critical syntheses that consolidate knowledge and identify future priorities.

Case/Practice Reports

Well-documented clinical or practice innovations with generalizable lessons.

Editorials & Perspectives

Commentaries on emerging issues in pharmaceutical research, policy, and practice.

Peer Review Model: The Peer Review Policy specifies a double-blind process: authors and reviewers are anonymized, with at least two independent reviews prior to a final decision by the Editor-in-Chief.

Open Access, Copyright & Fees

As detailed on the Open Access Policy, articles are immediately and permanently available. The Licensing Policy specifies CC BY 4.0, permitting sharing, adaptation, and commercial use with attribution.

Item Amount (USD) Source
Standard APC (APPS) $2,949 APC Page

Waiver/discount conditions and eligibility (e.g., up to 50% waiver; low- and lower-middle-income country considerations) are described on the APC and Waiver Policy pages.

Discoverability & Archiving

The site header highlights presence in Index Copernicus with the ICV value. APPS also provides RSS feeds and issue navigation for discoverability. Authors should include accurate metadata (affiliations, ORCID where applicable) during submission to optimize indexing and retrieval. Source: Homepage

  • Persistent identifiers (DOIs) and full-text availability support citation and reuse.
  • Policy pages detail publication ethics, licensing, and archiving expectations available on the journal site.

What Authors, Reviewers & Editors Can Expect

For Authors

  • Constructive peer review and prompt editorial communication (as described across policy pages).
  • Transparent open-access licensing (CC BY 4.0) and visible APC schedule.
  • No submission fees; APC payable only upon acceptance. Source

For Reviewers & Editors

  • Double-blind process preserves anonymity and fairness. Source
  • Editorial guidelines linked from the site for role clarity.

Contact the Editorial Office

For scope questions, presubmission checks, or APC/waiver queries, contact:

Emails are listed on multiple policy pages (APC, Open Access, Licensing, Peer Review). Sources: APC, Open Access, Licensing, Peer Review.